NO167143C - Analogifremgangsmaate ved fremstilling av et terapeutisk aktivt (-)-1beta-ethyl-1alfa-hydroxymethyl-1,2,3,4,6,7,12,12balfa-octahydro-indolo(2,3-a)kinolizin. - Google Patents
Analogifremgangsmaate ved fremstilling av et terapeutisk aktivt (-)-1beta-ethyl-1alfa-hydroxymethyl-1,2,3,4,6,7,12,12balfa-octahydro-indolo(2,3-a)kinolizin.Info
- Publication number
- NO167143C NO167143C NO861539A NO861539A NO167143C NO 167143 C NO167143 C NO 167143C NO 861539 A NO861539 A NO 861539A NO 861539 A NO861539 A NO 861539A NO 167143 C NO167143 C NO 167143C
- Authority
- NO
- Norway
- Prior art keywords
- kinolizin
- 12balfa
- 1alfa
- indolo
- 1beta
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU851519A HU194221B (en) | 1985-04-19 | 1985-04-19 | Process for preparing novel octahydro-indolo/2,3-a/quinoline derivative and pharmaceutical comprising this compound |
Publications (3)
Publication Number | Publication Date |
---|---|
NO861539L NO861539L (no) | 1986-10-20 |
NO167143B NO167143B (no) | 1991-07-01 |
NO167143C true NO167143C (no) | 1991-10-09 |
Family
ID=10954847
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO861539A NO167143C (no) | 1985-04-19 | 1986-04-18 | Analogifremgangsmaate ved fremstilling av et terapeutisk aktivt (-)-1beta-ethyl-1alfa-hydroxymethyl-1,2,3,4,6,7,12,12balfa-octahydro-indolo(2,3-a)kinolizin. |
Country Status (35)
Country | Link |
---|---|
US (1) | US4806545A (fr) |
JP (1) | JPH072637B2 (fr) |
CN (1) | CN1023560C (fr) |
AR (1) | AR240699A1 (fr) |
AT (1) | AT390954B (fr) |
AU (1) | AU591896B2 (fr) |
BE (1) | BE904588A (fr) |
BG (1) | BG60433B2 (fr) |
CA (1) | CA1299574C (fr) |
CH (1) | CH668262A5 (fr) |
CS (1) | CS274276B2 (fr) |
DD (1) | DD244556A5 (fr) |
DE (1) | DE3613180C2 (fr) |
DK (1) | DK159780C (fr) |
EG (1) | EG18059A (fr) |
ES (1) | ES8706152A1 (fr) |
FI (1) | FI83870C (fr) |
FR (1) | FR2580649B1 (fr) |
GB (1) | GB2174701B (fr) |
GR (1) | GR861027B (fr) |
HU (1) | HU194221B (fr) |
IE (1) | IE59199B1 (fr) |
IL (1) | IL78538A (fr) |
IN (1) | IN162810B (fr) |
IT (1) | IT1204306B (fr) |
LU (1) | LU86397A1 (fr) |
NL (1) | NL8600976A (fr) |
NO (1) | NO167143C (fr) |
NZ (1) | NZ215879A (fr) |
PH (1) | PH25316A (fr) |
PT (1) | PT82424B (fr) |
SE (1) | SE460196B (fr) |
SU (1) | SU1438612A3 (fr) |
YU (1) | YU44286B (fr) |
ZA (1) | ZA862941B (fr) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU191454B (en) * | 1984-10-05 | 1987-02-27 | Richter Gedeon Vegyeszeti Gyar Rt.,Hu | Process for producing amides of oktahydro-indolo/2,3-a/quinolyzin-1-yl-alkanecarboxylic acids and pharmaceutically acceptable acid additional salts thereof |
HU194220B (en) * | 1985-04-19 | 1988-01-28 | Richter Gedeon Vegyeszet | Process for production of derivatives of 1,12 b disubstituated-octahydro-indolo /2,3-a/ quinolisine and medical compounds containing thereof |
HU195214B (en) * | 1985-04-19 | 1988-04-28 | Richter Gedeon Vegyeszet | Process for producing 12b-substituted-1-(hydroxymethyl)-octahydro-indolo /2,3-a/ quinolizine derivatives and pharmaceutical preparations comprising these compounds |
HU207070B (en) * | 1990-10-31 | 1993-03-01 | Richter Gedeon Vegyeszet | Process for producing 1beta-ethyl-1alpha-hydroxymethyl-1,2,3,4,6,712,12balpha-octahydroindolo(2,3-a) quinolizine |
DE19821039A1 (de) * | 1998-05-11 | 1999-11-18 | Bayer Ag | Verfahren zur Herstellung von (S,S)-Benzyl-2,8-diazabicyclo[4.3.0]nonan |
EP1490361B1 (fr) * | 2002-04-03 | 2007-10-03 | Orion Corporation | Composes polycycliques comme antagonistes puissants des recepteurs alpha2-adrenergiques |
AU2003235931A1 (en) * | 2002-05-13 | 2003-11-11 | Takata Seiyaku Co., Ltd. | Vintoperol-containing medicinal composition for transdermal administration |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1499546A (en) * | 1974-05-07 | 1978-02-01 | Richter Gedeon Vegyeszet | Indolo-quinolizidine derivatives and a process for the preparation thereof |
HU170495B (fr) * | 1974-05-07 | 1977-06-28 | ||
HU194220B (en) * | 1985-04-19 | 1988-01-28 | Richter Gedeon Vegyeszet | Process for production of derivatives of 1,12 b disubstituated-octahydro-indolo /2,3-a/ quinolisine and medical compounds containing thereof |
HU195214B (en) * | 1985-04-19 | 1988-04-28 | Richter Gedeon Vegyeszet | Process for producing 12b-substituted-1-(hydroxymethyl)-octahydro-indolo /2,3-a/ quinolizine derivatives and pharmaceutical preparations comprising these compounds |
-
1985
- 1985-04-19 HU HU851519A patent/HU194221B/hu not_active IP Right Cessation
-
1986
- 1986-04-11 PH PH33639A patent/PH25316A/en unknown
- 1986-04-14 BE BE1/011476A patent/BE904588A/fr not_active IP Right Cessation
- 1986-04-14 US US06/851,327 patent/US4806545A/en not_active Expired - Fee Related
- 1986-04-16 CH CH1514/86A patent/CH668262A5/de not_active IP Right Cessation
- 1986-04-17 YU YU624/86A patent/YU44286B/xx unknown
- 1986-04-17 EG EG215/86A patent/EG18059A/xx active
- 1986-04-17 NL NL8600976A patent/NL8600976A/nl not_active Application Discontinuation
- 1986-04-18 AU AU56383/86A patent/AU591896B2/en not_active Ceased
- 1986-04-18 IL IL78538A patent/IL78538A/xx not_active IP Right Cessation
- 1986-04-18 DK DK179786A patent/DK159780C/da active
- 1986-04-18 DE DE3613180A patent/DE3613180C2/de not_active Expired - Fee Related
- 1986-04-18 FR FR868605610A patent/FR2580649B1/fr not_active Expired - Fee Related
- 1986-04-18 NZ NZ215879A patent/NZ215879A/xx unknown
- 1986-04-18 SU SU864027292A patent/SU1438612A3/ru active
- 1986-04-18 AT AT0102986A patent/AT390954B/de not_active IP Right Cessation
- 1986-04-18 NO NO861539A patent/NO167143C/no unknown
- 1986-04-18 CA CA000507011A patent/CA1299574C/fr not_active Expired - Fee Related
- 1986-04-18 IT IT20136/86A patent/IT1204306B/it active
- 1986-04-18 PT PT82424A patent/PT82424B/pt not_active IP Right Cessation
- 1986-04-18 DD DD86289372A patent/DD244556A5/de not_active IP Right Cessation
- 1986-04-18 SE SE8601799A patent/SE460196B/sv not_active IP Right Cessation
- 1986-04-18 FI FI861641A patent/FI83870C/fi not_active IP Right Cessation
- 1986-04-18 LU LU86397A patent/LU86397A1/de unknown
- 1986-04-18 ES ES554143A patent/ES8706152A1/es not_active Expired
- 1986-04-18 CS CS286386A patent/CS274276B2/cs unknown
- 1986-04-18 GB GB08609533A patent/GB2174701B/en not_active Expired
- 1986-04-18 AR AR30369386A patent/AR240699A1/es active
- 1986-04-18 ZA ZA862941A patent/ZA862941B/xx unknown
- 1986-04-18 IN IN292/MAS/86A patent/IN162810B/en unknown
- 1986-04-18 IE IE103386A patent/IE59199B1/en not_active IP Right Cessation
- 1986-04-18 JP JP61088398A patent/JPH072637B2/ja not_active Expired - Lifetime
- 1986-04-18 GR GR861027A patent/GR861027B/el unknown
- 1986-04-19 CN CN86102479A patent/CN1023560C/zh not_active Expired - Lifetime
-
1993
- 1993-12-10 BG BG098290A patent/BG60433B2/bg unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO167572C (no) | Analogifremgangsmaate for fremstilling av et terapeutisk aktivt purinderivat. | |
NO162238C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydro-4-oksonaftyridinderivater. | |
NO851949L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive aminotetralinderivater. | |
NO171272C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,2,4-triazolforbindelser | |
NO166080C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 5,6,8-trifluorkinoliner. | |
NO864879L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tiazolforbindelser. | |
NO864674D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive cefemforbindelser. | |
NO166326C (no) | Fremgangsmaate ved fremstilling av terapeutisk aktive 3,7-substituerte-8-oxo-5-thia-1-azabicyclo-(4,2,0)oct-2-en-2-carboxylater. | |
NO863671L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydro-2-heterocykloalkylpyrido(4,3)indoler. | |
NO862373D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tienopyridoner. | |
NO159086C (no) | Analogifremgangsmaate ved fremstilling av et terapeutisk aktivt triazolderivat. | |
NO168107C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 1,4-dihydropyridiner | |
NO167797C (no) | Analogifremgangsmaate for fremstilling av et terapeutisk aktivt nitrometan. | |
NO165400C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive cefemforbindelser. | |
NO163954C (no) | Analogifremgangsmaate for fremstilling av et terapeutisk aktivt amidinderivat. | |
NO873108D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive 1,4-benzodiazepiner. | |
NO165069C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive cyklopentyletere. | |
NO164020C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive fenetanolaminderivater. | |
NO161313C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive fluorallylaminderivater. | |
NO167143C (no) | Analogifremgangsmaate ved fremstilling av et terapeutisk aktivt (-)-1beta-ethyl-1alfa-hydroxymethyl-1,2,3,4,6,7,12,12balfa-octahydro-indolo(2,3-a)kinolizin. | |
NO165542C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-aryl-2,4-dialkyl-3h-1,2,4-triazol-3-thioner. | |
NO862390D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydropyridinderivater. | |
NO164239C (no) | Analogifremgangsmaate for fremstilling av et terapeutisk aktivt karbapenemderivat. | |
NO166642C (no) | Anaolgifremgangsmaate for fremstilling av terapeutisk aktive 3-aryl-5-alkylthio-4h-1,2,4-triazoler. | |
NO168247C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-metoksy-alkyl-ammonium-tetrahydrofuraner. |